相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Molecular characterization of autophagic and apoptotic signaling induced by sorafenib in liver cancer cells
Maria A. Rodriguez-Hernandez et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Thioredoxin and glutaredoxin regulate metabolism through different multiplex thiol switches
M. J. Lopez-Grueso et al.
REDOX BIOLOGY (2019)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Cysteine residues are essential for dimerization of Hippo pathway components YAP2L and TAZ
Prem Khanal et al.
SCIENTIFIC REPORTS (2018)
The Hippo Signaling Network and Its Biological Functions
Jyoti R. Misra et al.
ANNUAL REVIEW OF GENETICS, VOL 52 (2018)
Metabolic reprogramming and epithelial-to-mesenchymal transition in cancer
Marco Sciacovelli et al.
FEBS JOURNAL (2017)
The complex roles of STAT3 and STAT5 in maintaining redox balance: Lessons from STAT-mediated xCT expression in cancer cells
Katja Linher-Melville et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2017)
Activation of phosphatidylinositol 3-kinase/AKT/snail signaling pathway contributes to epithelial-mesenchymal transition-induced multi-drug resistance to sorafenib in hepatocellular carcinoma cells
Jiejie Dong et al.
PLOS ONE (2017)
Phosphatase PTP4A3 Promotes Triple-Negative Breast Cancer Growth and Predicts Poor Patient Survival
Petra den Hollander et al.
CANCER RESEARCH (2016)
Metformin inhibits the prometastatic effect of sorafenib in hepatocellular carcinoma by upregulating the expression of TIP30
Zhigui Guo et al.
CANCER SCIENCE (2016)
Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
Jordi Bruix et al.
GASTROENTEROLOGY (2016)
Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ)
Rajesh Kumar Gandhirajan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Accuracy of novel diagnostic biomarkers for hepatocellular carcinoma: An update for clinicians
Patrick Reichl et al.
ONCOLOGY REPORTS (2016)
SDHB deficiency promotes TGFβ-mediated invasion and metastasis of colorectal cancer through transcriptional repression complex SNAIL1-SMAD3/4
Haiyu Wang et al.
TRANSLATIONAL ONCOLOGY (2016)
PI3K/AKT pathway regulates E-cadherin and Desmoglein 2 in aggressive prostate cancer
Alison G. Barber et al.
CANCER MEDICINE (2015)
Redox regulation of metabolic and signaling pathways by thioredoxin and glutaredoxin in NOS-3 overexpressing hepatoblastoma cells
Raul Gonzalez et al.
REDOX BIOLOGY (2015)
Peroxiredoxin-2 and STAT3 form a redox relay for H2O2 signaling
Mirko C. Sobotta et al.
NATURE CHEMICAL BIOLOGY (2015)
S-Glutathionylation at Cys328 and Cys542 Impairs STAT3 Phosphorylation
Elena Butturini et al.
ACS CHEMICAL BIOLOGY (2014)
Molecular mechanisms of epithelial-mesenchymal transition
Samy Lamouille et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Co-delivery of thioredoxin 1 shRNA and doxorubicin by folate-targeted gemini surfactant-based cationic Liposomes to sensitize hepatocellular carcinoma cells
Wenjie Li et al.
JOURNAL OF MATERIALS CHEMISTRY B (2014)
Succinate dehydrogenase inhibition leads to epithelial-mesenchymal transition and reprogrammed carbon metabolism
Paul-Joseph P. Aspuria et al.
CANCER & METABOLISM (2014)
Synergistic antitumour activity of sorafenib in combination with tetrandrine is mediated by reactive oxygen species (ROS)/Akt signaling
J. Wan et al.
BRITISH JOURNAL OF CANCER (2013)
Roles of thioredoxin binding protein (TXNIP) in oxidative stress, apoptosis and cancer
Jianbiao Zhou et al.
MITOCHONDRION (2013)
Deficiency of Thioredoxin Binding Protein-2 (TBP-2) Enhances TGF-β Signaling and Promotes Epithelial to Mesenchymal Transition
So Masaki et al.
PLOS ONE (2012)
Modulation of Gene Expression and Tumor Cell Growth by Redox Modification of STAT3
Li Li et al.
CANCER RESEARCH (2010)
Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver
Li Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
S-Glutathionylation Impairs Signal Transducer and Activator of Transcription 3 Activation and Signaling
Yi Xie et al.
ENDOCRINOLOGY (2009)
Epithelial-mesenchymal transition in hepatocellular carcinoma
Franziska van Zijl et al.
FUTURE ONCOLOGY (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
Surveillance for hepatocellular carcinoma in patients with cirrhosis improves outcome
Richard Todd Stravitz et al.
AMERICAN JOURNAL OF MEDICINE (2008)
Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells
Bryan C. Fuchs et al.
CANCER RESEARCH (2008)
MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification
Juergen Cox et al.
NATURE BIOTECHNOLOGY (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Complex networks orchestrate epithelial-mesenchymal transitions
JP Thiery et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Epithelial-mesenchymal transition in development and cancer:: role of phosphatidylinositol 3′ kinase/AKT pathways
L Larue et al.
ONCOGENE (2005)
Glutaredoxin exerts an antiapoptotic effect by regulating the redox state of Akt
H Murata et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Crystal structure of an inactive Akt2 kinase domain
X Huang et al.
STRUCTURE (2003)
Functional and genomic implications of global gene expression profiles in cell lines from human hepatocellular cancer
JS Lee et al.
HEPATOLOGY (2002)
分享论文
